Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anaerobic glycolysis is a biochemical pathway in which glucose is converted to pyruvate in the absence of oxygen, and pyruvate is subsequently reduced to lactate, regenerating NAD⁺ required for glycolysis to continue. This process provides a rapid but inefficient means (2 net ATP per glucose) of generating ATP compared to aerobic respiration, which can yield up to 32 ATP per glucose. Anaerobic glycolysis is especially important when oxygen is limited, such as during intense exercise, in red blood cells (which lack mitochondria), and under various pathological conditions. The pathway operates in the cytoplasm and includes multiple enzyme-catalyzed steps, with essential regulatory control points at hexokinase, phosphofructokinase, and pyruvate kinase. The final conversion of pyruvate to lactate is catalyzed by lactate dehydrogenase.
Enzyme inhibition (blocking specific glycolytic enzymes) Depletion of pathway intermediates (rare and primarily research tools)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycolysis pathway, anaerobic.